By Ben James ( November 20, 2012, 5:05 PM EST) -- Momenta Pharmaceuticals Inc. plans to seek U.S. Supreme Court review of a Federal Circuit decision that overturned an injunction against Amphastar Pharmaceuticals Inc. and said a lower court had interpreted the Hatch-Waxman Act's safe harbor provision too narrowly, Momenta said Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.